Literature DB >> 22013907

Cognitive alterations in patients with non-affective psychotic disorder and their unaffected siblings and parents.

J Meijer1, C J P Simons, P J Quee, K Verweij.   

Abstract

OBJECTIVE: The purpose of this study was to examine a range of cognitive measures as candidate phenotypic liability markers for psychosis in a uniquely large sample of patients with psychosis, their unaffected relatives and control subjects.
METHOD: Patients with non-affective psychosis (n = 1093), their unaffected siblings (n = 1044), parents (n = 911), and controls (n = 587) completed a comprehensive cognitive test battery. Cognitive functioning was compared using tests of verbal learning and memory, attention/vigilance, working memory, processing speed, reasoning and problem solving, acquired knowledge, and social cognition. Age- and gender-adjusted z-scores were compared between groups using mixed-model analyses of covariance. Clinically relevant impairment (-1 and -2 SD from control mean) was compared between subject groups.
RESULTS: Patients performed significantly worse than controls in all cognitive domains (z-range -0.26 to -1.34). Siblings and parents showed alterations for immediate verbal learning, processing speed, reasoning and problem solving, acquired knowledge, and working memory (z-range -0.22 to -0.98). Parents showed additional alterations for social cognition. Prevalence of clinically relevant impairment in relatives ranged from 50% (-1 SD criterion) to 10% (-2 SD criterion).
CONCLUSION: Cognitive functioning is a candidate intermediate phenotype given significant small to large alterations in patients and intermediate alterations in first-degree relatives.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2011        PMID: 22013907     DOI: 10.1111/j.1600-0447.2011.01777.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  10 in total

1.  Childhood abuse and neglect may induce deficits in cognitive precursors of psychosis in high-risk children.

Authors:  Nicolas Berthelot; Thomas Paccalet; Elsa Gilbert; Isabel Moreau; Chantal Mérette; Nathalie Gingras; Nancie Rouleau; Michel Maziade
Journal:  J Psychiatry Neurosci       Date:  2015-09       Impact factor: 6.186

2.  Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.

Authors:  Ana M Sánchez-Torres; Virginia Basterra; Araceli Rosa; Lourdes Fañanás; Amalia Zarzuela; Berta Ibáñez; Víctor Peralta; Manuel J Cuesta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-04-12       Impact factor: 5.270

3.  Differential Time Course of Microstructural White Matter in Patients With Psychotic Disorder and Individuals at Risk: A 3-Year Follow-up Study.

Authors:  Patrick Domen; Sanne Peeters; Stijn Michielse; Ed Gronenschild; Wolfgang Viechtbauer; Alard Roebroeck; Jim van Os; Machteld Marcelis
Journal:  Schizophr Bull       Date:  2016-05-17       Impact factor: 9.306

Review 4.  The global cognitive impairment in schizophrenia: consistent over decades and around the world.

Authors:  Jonathan Schaefer; Evan Giangrande; Daniel R Weinberger; Dwight Dickinson
Journal:  Schizophr Res       Date:  2013-08-02       Impact factor: 4.939

5.  Cognitive Performance and Long-Term Social Functioning in Psychotic Disorder: A Three-Year Follow-Up Study.

Authors:  Claudia J P Simons; Agna A Bartels-Velthuis; Gerdina H M Pijnenborg
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

6.  Psychiatric symptoms and related dysfunction in a general population sample.

Authors:  Lauren Smith; Abraham Reichenberg; Jonathan Rabinowitz; Stephen Z Levine; Eva Velthorst
Journal:  Schizophr Res Cogn       Date:  2018-08-11

7.  UP'S: A Cohort Study on Recovery in Psychotic Disorder Patients: Design Protocol.

Authors:  Bernice C van Aken; Ayuk Bakia; André I Wierdsma; Yolande Voskes; Jaap Van Weeghel; Evelyn M M van Bussel; Carla Hagestein; Andrea M Ruissen; Pien Leendertse; Wishal V Sewbalak; Daphne A van der Draai; Alice Hammink; M E Mandos; Mark van der Gaag; Annette E Bonebakker; Christina M Van Der Feltz-Cornelis; Cornelis L Mulder
Journal:  Front Psychiatry       Date:  2021-01-12       Impact factor: 4.157

8.  Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History.

Authors:  Ana González-Pinto; Itxaso González-Ortega; Susana Alberich; Sonia Ruiz de Azúa; Miguel Bernardo; Miquel Bioque; Bibiana Cabrera; Iluminada Corripio; Celso Arango; Antonio Lobo; Ana M Sánchez-Torres; Manuel J Cuesta
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

9.  Long-term cognitive trajectories and heterogeneity in patients with schizophrenia and their unaffected siblings.

Authors:  Md A Islam; T D Habtewold; F D van Es; P J Quee; E R van den Heuvel; B Z Alizadeh; R Bruggeman
Journal:  Acta Psychiatr Scand       Date:  2018-09-21       Impact factor: 6.392

10.  Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case-Control Study.

Authors:  Giada Tripoli; Diego Quattrone; Laura Ferraro; Charlotte Gayer-Anderson; Caterina La Cascia; Daniele La Barbera; Crocettarachele Sartorio; Fabio Seminerio; Victoria Rodriguez; Ilaria Tarricone; Domenico Berardi; Stéphane Jamain; Celso Arango; Andrea Tortelli; Pierre-Michel Llorca; Lieuwe de Haan; Eva Velthorst; Julio Bobes; Miquel Bernardo; Julio Sanjuán; Jose Luis Santos; Manuel Arrojo; Cristina Marta Del-Ben; Paulo Rossi Menezes; Els van der Ven; Peter B Jones; Hannah E Jongsma; James B Kirkbride; Sarah Tosato; Antonio Lasalvia; Alex Richards; Michael O'Donovan; Bart P F Rutten; Jim van Os; Craig Morgan; Pak C Sham; Marta Di Forti; Robin M Murray; Graham K Murray
Journal:  Schizophr Bull       Date:  2022-09-01       Impact factor: 7.348

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.